A carregar...

Differential Reponses of Hematopoietic Stem and Progenitor Cells to mTOR Inhibition

Abnormal activation of the mammalian target of rapamycin (mTOR) signaling pathway has been observed in a variety of human cancers. Therefore, targeting of the mTOR pathway is an attractive strategy for cancer treatment and several mTOR inhibitors, including AZD8055 (AZD), a novel dual mTORC1/2 inhib...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Stem Cells Int
Main Authors: Yang, Aimin, Xiao, Xia, Zhao, Mingfeng, LaRue, Amanda C., Schulte, Bradley A., Wang, Gavin Y.
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi Publishing Corporation 2015
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4499403/
https://ncbi.nlm.nih.gov/pubmed/26221145
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/561404
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!